1Tanabe K, Takahashi K, Sonda K, et al. Long-term results of ABO-incompatible living kidney transplantation: a singlecenter experience. Transplantation, 1998, 65(2):224-228.
2Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant, 2004, 4(7) : 1089-1096.
3Takahashi K, Saito K, Tanabe K, et al. First report of a 7- year survey on ABO-incompatible kidney transplantation in Japan. Clin Exp Nephrol, 2001, 5(1 ) : 119-125.
4Knoll GA, Bell RC. Taerolimus versus eyelosporin for immunosuppression in renal transplantation: meta-analysis of randomized trials. BMJ, 1999, 318(7191) :1104-1107.
5Margreiter R. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in renal transplantation: a randomized multicentre study. Lancet, 2002, 359(9308):741-746.
6Alexandre GP, Squifflet JP, De Bruyere M, et al. Spleneetomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proe, 1985, 17 (2): 138- 143.
7Ishida H, Furusawa M, Murakami T, et al. Outcome of an ABO-incompatible renal transplant without splenectomy. Transplant Int, 2002, 15(1) :56-58.
9Tyden G, Kumlien G, Genberg H, et al. ABO-incompatible renal transplantation without splenectomy, using antigenspecific immunoadsorption and rituximab. Am J Transplant,2005, 5(1):145-148.
10Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow AEO- incompatible renal transplantation without splenectomy. Am J Transplant, 2004, 4(8):1315-1322.
